S&P Futures
4,604.50 -3.00 (-0.07%) Dow Futures
36,272.00 -8.00 (-0.02%) Nasdaq Futures
16,074.25 -24.00 (-0.15%) Russell 2000 Futures
1,900.70 -1.30 (-0.07%) Crude Oil
70.65 -0.58 (-0.81%) Gold
2,007.90 -6.60 (-0.33%)
Inogen Inc (6IO.SG)
Chart Events
Performance Outlook
| Previous Close | 5.45 |
| Open | 5.40 |
| Bid | 5.40 x 200000 |
| Ask | 5.65 x 200000 |
| Day's Range | 5.40 - 5.40 |
| 52 Week Range | 3.92 - 24.00 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Feb 21, 2024 - Feb 26, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for 6IO.SG
Related Research
ZacksInogen (INGN) Down 4.2% Since Last Earnings Report: Can It Rebound?
Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Business WireInogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO
GOLETA, Calif., November 13, 2023--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of Directors has appointed Kevin Smith as Inogen’s President and Chief Executive Officer and a member of the Board of Directors, effective immediately, succeeding Nabil Shabshab.
ZacksInogen (INGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
